Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001

In 2024, glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 trade exhibited significant decline, with global flows reaching $3,557,168,246 and a three-year compound annual growth rate of -14.4% (five-year: -2.9%). The all-time peak of $5,975,137,479 was recorded in 2022; the current level is 40% below that high-water mark.

Over the 30-year observation window (1995–2024), 69% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is decelerating (-12.2% acceleration).

The World Trade Flows Characterization classifies glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 as "Two-way trade" in the unclassified price segment, providing additional context for market positioning and competitive dynamics.

The supply side is diversified (Herfindahl-Hirschman Index 0.116). The three largest exporters — China ($786.1M), United States ($647.7M), and Singapore ($432.1M) — collectively dominate supply flows. The leading exporter has grown at -22.3% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.062). The three largest import markets are France ($585.2M), United States ($384.6M), and Singapore ($238.0M). The largest importing market sources from 75 different supplying countries.

Estimated substitution elasticity: -57.25. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is France → Singapore at $224.2M, representing 94.2% of the importer's total demand.

The volatility score for glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 is 21 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.